ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.89896
-0.05%
Brent Oil
83.56
0.84%
Bitcoin
61,206.40
-1.81%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Intersect ENT Inc (XENT)

  7. Intersect ENT Inc (XENT) Noticias

XENT

Intersect ENT (XENT)

Intersect ENT Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XENT
FechaHoraFuenteTítuloSímboloCompañía
10/02/202315:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XENTIntersect ENT Inc
12/09/202212:11Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:XENTIntersect ENT Inc
19/05/202215:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XENTIntersect ENT Inc
18/05/202205:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XENTIntersect ENT Inc
16/05/202217:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XENTIntersect ENT Inc
13/05/202208:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:XENTIntersect ENT Inc
13/05/202208:01Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:XENTIntersect ENT Inc
13/05/202207:59Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:XENTIntersect ENT Inc
09/05/202216:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XENTIntersect ENT Inc
04/05/202215:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XENTIntersect ENT Inc
29/04/202215:04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XENTIntersect ENT Inc
08/03/202215:14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XENTIntersect ENT Inc
08/03/202215:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XENTIntersect ENT Inc
31/01/202213:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XENTIntersect ENT Inc
25/01/202206:00Business WireReal-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource UtilizationNASDAQ:XENTIntersect ENT Inc
02/11/202115:15Business WireIntersect ENT Reports Third Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
28/10/202106:00Business WireFirst Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in EuropeNASDAQ:XENTIntersect ENT Inc
30/09/202115:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XENTIntersect ENT Inc
19/08/202107:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XENTIntersect ENT Inc
09/08/202113:47PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Intersect ENT, Inc.NASDAQ:XENTIntersect ENT Inc
09/08/202110:07TipRanksMedtronic Gains Investor Confidence with Intersect BuyoutNASDAQ:XENTIntersect ENT Inc
09/08/202104:55TipRanksIntersect ENT’s Q2 Results Miss Expectations; Shares Jump on Acquisition NewsNASDAQ:XENTIntersect ENT Inc
06/08/202109:24Dow Jones NewsIntersect ENT Shares Rise on Medtronic Takeover DealNASDAQ:XENTIntersect ENT Inc
06/08/202106:48Dow Jones NewsMedtronic to Buy Intersect ENT for $28.25/ShareNASDAQ:XENTIntersect ENT Inc
06/08/202106:15Business WireIntersect ENT Reports Second Quarter 2021 Financial ResultsNASDAQ:XENTIntersect ENT Inc
06/08/202106:00PR Newswire (US)Medtronic to Acquire Intersect ENTNASDAQ:XENTIntersect ENT Inc
26/07/202106:00Business WireU.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic RhinosinusitisNASDAQ:XENTIntersect ENT Inc
23/07/202107:00Business WireIntersect ENT to Report Second Quarter 2021 Financial Results on August 6NASDAQ:XENTIntersect ENT Inc
22/07/202115:05Business WireIntersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term LoanNASDAQ:XENTIntersect ENT Inc
20/05/202106:46Business WireIntersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus...NASDAQ:XENTIntersect ENT Inc
 Showing the most relevant articles for your search:NASDAQ:XENT

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
FX
EURMXN
Euro vs MXN
CCOM
OILBRENT
Brent Oil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados